Hopital Albert Michallon

Grenoble, Auvergne-Rhône-Alpes 38043

0 studies enrolling now · 2 studies all time

What they study most

ALK+ Advanced NSCLC, Advanced Malignancies, Carcinoma, Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants — Completed